Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02893514 · ClinicalTrials.gov registry record · NA
Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT02893514 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 79 participants.
The verdict
NCT02893514, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
This study will develop a clinical decision support tool that assists primary care providers in carrying out substance use interventions, and then compare (in Phase 2) two clinical scenarios, screening only (SO) vs. SUSIT, (on dose of substance use brief intervention received) and changes in drug use at 3 and 6 months, among primary care patients. Investigators will develop the Clinical Decision Support (CDS) component and then test the full SUSIT approach, using mixed methods to assess its acceptability and adoption, and gathering preliminary data on its efficacy for reducing unhealthy drug use. CDS development is concurrent with the SO phase to avoid losing valuable time, but will be conducted at a secondary study site to avoid contaminating the SO condition.
Interventions
- OTHER Screening Only (SO) condition
- OTHER SUSIT Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2017-04-13 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02893514
The ClinicalTrials.gov registry entry for NCT02893514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Screening Only (SO) condition is the first listed.
NCT02893514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02893514 about?
NCT02893514 is a clinical study titled "Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings". This study will develop a clinical decision support tool that assists primary care providers in carrying out substance use interventions, and then compare (in Phase 2) two clinical scenarios, screening only (SO) vs. SUSIT, (on dose of substance use brief intervention received) and changes in drug us...
What is the current status of trial NCT02893514?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2017-04-13. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT02893514?
The interventions under investigation include: Screening Only (SO) condition (OTHER), SUSIT Condition (OTHER).
Who is sponsoring clinical trial NCT02893514?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.